These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6141904)
1. Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism. Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M Drug Metab Dispos; 1984; 12(1):131-8. PubMed ID: 6141904 [TBL] [Abstract][Full Text] [Related]
2. Effect of quinidine on the 10-hydroxylation of R-warfarin: species differences and clearance projection. Chen Q; Tan E; Strauss JR; Zhang Z; Fenyk-Melody JE; Booth-Genthe C; Rushmore TH; Stearns RA; Evans DC; Baillie TA; Tang W J Pharmacol Exp Ther; 2004 Oct; 311(1):307-14. PubMed ID: 15163679 [TBL] [Abstract][Full Text] [Related]
3. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875 [TBL] [Abstract][Full Text] [Related]
4. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments. Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317 [TBL] [Abstract][Full Text] [Related]
5. Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data. Ashforth EI; Carlile DJ; Chenery R; Houston JB J Pharmacol Exp Ther; 1995 Aug; 274(2):761-6. PubMed ID: 7636740 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Zhou S; Kestell P; Tingle MD; Paxton JW Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426 [TBL] [Abstract][Full Text] [Related]
7. Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human. Prueksaritanont T; Balani SK; Dwyer LM; Ellis JD; Kauffman LR; Varga SL; Pitzenberger SM; Theoharides AD Drug Metab Dispos; 1995 Jul; 23(7):688-95. PubMed ID: 7587955 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Brown HS; Griffin M; Houston JB Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764 [TBL] [Abstract][Full Text] [Related]
9. Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats. Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M J Pharmacokinet Biopharm; 1982 Jun; 10(3):297-316. PubMed ID: 7175701 [TBL] [Abstract][Full Text] [Related]
10. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Riley RJ; McGinnity DF; Austin RP Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954 [TBL] [Abstract][Full Text] [Related]
11. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance. Fagerholm U J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173 [TBL] [Abstract][Full Text] [Related]
12. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data. Iwatsubo T; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358 [TBL] [Abstract][Full Text] [Related]
13. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Obach RS Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025 [TBL] [Abstract][Full Text] [Related]
14. Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes. Iwatsubo T; Suzuki H; Shimada N; Chiba K; Ishizaki T; Green CE; Tyson CA; Yokoi T; Kamataki T; Sugiyama Y J Pharmacol Exp Ther; 1997 Aug; 282(2):909-19. PubMed ID: 9262358 [TBL] [Abstract][Full Text] [Related]
15. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance. Griffin SJ; Houston JB Drug Metab Dispos; 2004 May; 32(5):552-8. PubMed ID: 15100178 [TBL] [Abstract][Full Text] [Related]
16. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513 [TBL] [Abstract][Full Text] [Related]
17. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. Kumar S; Samuel K; Subramanian R; Braun MP; Stearns RA; Chiu SH; Evans DC; Baillie TA J Pharmacol Exp Ther; 2002 Dec; 303(3):969-78. PubMed ID: 12438516 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Takahashi H; Kashima T; Kimura S; Murata N; Takaba T; Iwade K; Abe T; Tainaka H; Yasumori T; Echizen aH Drug Metab Dispos; 1999 Oct; 27(10):1179-86. PubMed ID: 10497145 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased. Makita T; Aiba T; Izuwa Y; Komori Y; Kawasaki H; Kurosaki Y Biopharm Drug Dispos; 2009 Jan; 30(1):1-8. PubMed ID: 19148953 [TBL] [Abstract][Full Text] [Related]
20. Polysaccharide peptides from COV-1 strain of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo. Yeung JH; Chan SL; Or PM Food Chem Toxicol; 2006 Aug; 44(8):1414-23. PubMed ID: 16698161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]